Bank of America Corp DE increased its position in Immunic, Inc. (IMUX) by 80,724.2% during the first quarter. The institution purchased an additional 143,689 shares. A 13F filing revealed the transaction on September 13, 2026.
This acquisition brings Bank of America’s total holdings to 143,867 shares. The bank now maintains a 1.06% ownership stake in the biotechnology company. The position was valued at approximately $160,000 at the end of the reporting period.
Several other hedge funds and institutional investors also recently modified their positions in Immunic.